论文部分内容阅读
·ＤｅｐｏＴｅｃｈ公司抗癌药开始Ⅲ期临床美因研究药物释放的ＤｅｐｏＴｅｃｈ公司将其可注射的抗癌药物ＤＴＣ１０１（ＤｅｐｏＦｏａｍ）用于治疗胸膜瘤，已开始Ⅲ期临床试验。该公司的ＤｅｐｏＦｏａｍ是以脂类为基质的药物释放系统的阿糖胞苷胶囊，其缓释可以持续几...
· DepoTech Anticancer Drugs Begin Phase III Apoecokinetics DepoTech Corporation has started Phase III clinical trials of its injectable anticancer drug DTC101 (DepoFoam) for the treatment of pleural neoplasia. The company’s DepoFoam is a lipid-based drug delivery system of cytarabine capsules, the sustained release can last a few ...